Emerging evidence suggests that lipogenesis is significantly enhanced in cancer cells as compared to normal cells, and some key enzymes (such as FASN, ACLY, ACC and SCD) responsible for the fatty acid metabolism are frequently overexpressed in human cancer, at least partly due to the overexpression of SREBP1 gene [37]. The gene discussed is FASN; the disease is cancer.